Dacarbazine, Injection, USP, 200mg, vials packaged in individual cartons, Rx only, Manufactured by Hospira Australia 1 Lexia Place, Mulgrave, Victoria Australia 3170. NDC 61703-327-22.
Published December 31, 2014 · Recall initiated: November 25, 2014
Summary
FDA records drug Class III recall D-0313-2015, published December 31, 2014 and initiated November 25, 2014. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 3,306 vials; Lot: Lot #: B032223AA; Exp: July 2016. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Discoloration: Reconstituted solution may appear pink instead of colorless to pale yellow when stored per the labeled conditions.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Hospira Inc.
- Distributor
- Nationwide
- Lot
- Lot #: B032223AA; Exp: July 2016
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAInfant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, RxMay 31, 2017
- FDAMinibore Extension Set, 59 Inch with Spin Lock Collar, Non-DEHP, Latex-Free Intended use: For theJanuary 18, 2017
- FDAFentanyl Citrate Injection, USP, 100 mcg Fentanyl/ 2mL, Single Dose, 50 mcg/mL, Rx only, Hospira, Inc., LakeNovember 30, 2016
- FDASymbiq Two Channel Infuser; an Rx medical device infusion pump used to administer I.V. fluids. List numberNovember 16, 2016
- FDATri-mix #4 (Papaverine 30 mg, Phentolamine 1 mg, Prostaglandin-1 10 mcg/mL), packaged in 10 mL sterile glassDecember 31, 2014
- FDAMAYHEM capsules, Proprietary Blend 525 mg, Dietary Supplement, 60-count bottles, Chaotic-Labz, UPC 6 28586December 31, 2014
Questions about this recall
Was Dacarbazine, Injection, USP, 200mg, vials packaged in individual cartons, Rx only, Manufactured by Hospira Australia 1 Lexia Place, Mulgrave, Victoria Australia 3170. NDC 61703-327-22. recalled?
Yes. FDA published recall D-0313-2015 on December 31, 2014. Reported hazard: Discoloration: Reconstituted solution may appear pink instead of colorless to pale yellow when stored per the labeled conditions.
What should I do if I have this product?
Voluntary: Firm initiated · Letter